Contact
searchSearch
HMP Global

Medication Safety Topic Center

Featured Article

Poll
Pharmacy Benefit Managers vs Independent Pharmacies
03/25/2024
03/25/2024
Pharmacy Learning Network
Quiz
Reviewing the Stop Dangerous Pharmacies Act
03/07/2024
What is the Stop Dangerous Pharmacies Act?
What is the Stop Dangerous Pharmacies Act?
What is the Stop Dangerous...
03/07/2024
Pharmacy Learning Network
News
Global GLP-1 Agonist Market Trends
03/04/2024

Emry Lloyd

Emry Lloyd
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report...
03/04/2024
Pharmacy Learning Network
Poll
Ensuring Safe and Effective Use of Weight Loss Drugs
03/01/2024
03/01/2024
Pharmacy Learning Network
News
Subpotent Eye Solution Recalled
09/21/2023
Jolynn Tumolo
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries...
09/21/2023
Pharmacy Learning Network
News
Homeopathic Products Pulled
07/07/2023
Jolynn Tumolo
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products...
07/07/2023
Pharmacy Learning Network
News
Opioid Analgesic Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Antifungal Injection Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Label/Capsule Mix-Up Prompts Recall
06/30/2023
Jolynn Tumolo
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to...
06/30/2023
Pharmacy Learning Network
News
Class I Recall for Contaminated Hand Sanitizers
06/23/2023
Jolynn Tumolo
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued...
06/23/2023
Pharmacy Learning Network
News
Anticonvulsant Capsules Recalled
06/23/2023
Jolynn Tumolo
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been...
06/23/2023
Pharmacy Learning Network

Newsfeed

News
Global GLP-1 Agonist Market Trends
03/04/2024

Emry Lloyd

Emry Lloyd
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report...
03/04/2024
Pharmacy Learning Network
News
Subpotent Eye Solution Recalled
09/21/2023
Jolynn Tumolo
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries...
09/21/2023
Pharmacy Learning Network
News
Homeopathic Products Pulled
07/07/2023
Jolynn Tumolo
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products...
07/07/2023
Pharmacy Learning Network
News
Opioid Analgesic Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Antifungal Injection Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Label/Capsule Mix-Up Prompts Recall
06/30/2023
Jolynn Tumolo
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to...
06/30/2023
Pharmacy Learning Network
News
Class I Recall for Contaminated Hand Sanitizers
06/23/2023
Jolynn Tumolo
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued...
06/23/2023
Pharmacy Learning Network
News
Anticonvulsant Capsules Recalled
06/23/2023
Jolynn Tumolo
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been...
06/23/2023
Pharmacy Learning Network
News
Antifibrinolytic Drug Recalled
06/23/2023
Jolynn Tumolo
A recall has been issued by two firms for antifibrinolytic drug tablets, distributed throughout the United States, for failing to meet impurity/degradation specifications.
A recall has been issued by two firms for antifibrinolytic drug tablets, distributed throughout the United States, for failing to meet impurity/degradation specifications.
A recall has been issued by two...
06/23/2023
Pharmacy Learning Network
News
Injection Recalled After Manufacturer Halts Quality Program
06/16/2023
Jolynn Tumolo
A Class II recall has been issued for a prescription injection anticholinergic/antispasmodic drug due to the manufacturer discontinuing their quality assurance program.
A Class II recall has been issued for a prescription injection anticholinergic/antispasmodic drug due to the manufacturer discontinuing their quality assurance program.
A Class II recall has been...
06/16/2023
Pharmacy Learning Network
News
KIMMTRAK (tebentafusp-tebn) Injection Recalled Due to Subpotency
09/10/2025
Hannah Musick
A Class II recall has been issued for KIMMTRAK (tebentafusp-tebn) Injection due to subpotency, potentially reducing therapeutic effectiveness in patients with metastatic uveal melanoma.
A Class II recall has been issued for KIMMTRAK (tebentafusp-tebn) Injection due to subpotency, potentially reducing therapeutic effectiveness in patients with metastatic uveal melanoma.
A Class II recall has been...
09/10/2025
Pharmacy Learning Network
News
Class II Recall for Multiple Strengths of Chlorpromazine Tablets Due to Contaminated Packaging Material
09/10/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Chlorpromazine Hydrochloride Tablets due to the presence of a microorganism on polyester coil packaging, posing a potential contamination risk...
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Chlorpromazine Hydrochloride Tablets due to the presence of a microorganism on polyester coil packaging, posing a potential contamination risk...
The US Food and Drug...
09/10/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall for Multiple DermaRite Antiseptic and Analgesic Products Due to Dangerous Microbial Contamination
09/10/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class I recall for multiple DermaRite antiseptic and topical products due to contamination with Burkholderia cepacia, a dangerous bacteria that poses serious infection risks to vulnerable...
The US Food and Drug Administration (FDA) has issued a Class I recall for multiple DermaRite antiseptic and topical products due to contamination with Burkholderia cepacia, a dangerous bacteria that poses serious infection risks to vulnerable...
The US Food and Drug...
09/10/2025
Pharmacy Learning Network
News
FDA Class II Recall Issued for Doxepin Hydrochloride Capsules Due to Nitrosamine Impurity
08/13/2025
Juliet Gallagher
Alembic Pharmaceuticals Limited has voluntarily initiated a nationwide Class II recall of its doxepin hydrochloride capsules, USP, 10 mg.
Alembic Pharmaceuticals Limited has voluntarily initiated a nationwide Class II recall of its doxepin hydrochloride capsules, USP, 10 mg.
Alembic Pharmaceuticals Limited...
08/13/2025
Pharmacy Learning Network
News
Cardinal Health Recalls Select Xolair Auto-Injectors and Syringes
08/13/2025
Juliet Gallagher
The US Food and Drug Administration (FDA) has announced a Class II drug recall involving two separate lots of Xolair (omalizumab injection), a biologic produced by Genentech, Inc.
The US Food and Drug Administration (FDA) has announced a Class II drug recall involving two separate lots of Xolair (omalizumab injection), a biologic produced by Genentech, Inc.
The US Food and Drug...
08/13/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall for Aequita Compounded Semaglutide Products
08/13/2025
Juliet Gallagher
Aequita Pharmacy LLC, based in Kirkland, Washington, has initiated a voluntary recall of multiple formulations of its compounded semaglutide + cyanocobalamin injection solutions.
Aequita Pharmacy LLC, based in Kirkland, Washington, has initiated a voluntary recall of multiple formulations of its compounded semaglutide + cyanocobalamin injection solutions.
Aequita Pharmacy LLC, based in...
08/13/2025
Pharmacy Learning Network
News
RSV Pneumonia Leads to Elevated ICU Admissions and Mortality in Older Adults
08/08/2025
Grace Taylor, MS, MA
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus...
08/08/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall for Duloxetine Capsules Due to Nitrosamine Impurity
08/07/2025
Grace Taylor, MS, MA
A nationwide recall has been issued for Duloxetine 20 mg capsules after cancer-linked impurities above acceptable limits were detected.
A nationwide recall has been issued for Duloxetine 20 mg capsules after cancer-linked impurities above acceptable limits were detected.
A nationwide recall has been...
08/07/2025
Pharmacy Learning Network
News
FDA Class I Recall Issued for Cefazolin for Injection by Sandoz Due to Labeling Mix-Up
08/07/2025
Grace Taylor, MS, MA
Sandoz recalls over 200 000 vials of Cefazolin after a labeling mix-up with penicillin threatens serious medication errors.
Sandoz recalls over 200 000 vials of Cefazolin after a labeling mix-up with penicillin threatens serious medication errors.
Sandoz recalls over 200 000...
08/07/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall for Sucralfate Tablets Manufactured by Nostrum Laboratories
08/07/2025
Grace Taylor, MS, MA
Nostrum Laboratories has issued a nationwide recall of its Sucralfate Tablets due to quality concerns following a bankruptcy filing.
Nostrum Laboratories has issued a nationwide recall of its Sucralfate Tablets due to quality concerns following a bankruptcy filing.
Nostrum Laboratories has issued...
08/07/2025
Pharmacy Learning Network

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
More Evidence of Cardiovascular Harm With NSAIDs
04/13/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In light of a new study, Dr Jennings advocates for practicing pharmacists to discuss the potential cardiovascular harm associated with short-term use of nonsteroidal anti-inflammatory drugs.
In light of a new study, Dr Jennings advocates for practicing pharmacists to discuss the potential cardiovascular harm associated with short-term use of nonsteroidal anti-inflammatory drugs.
In light of a new study, Dr...
04/13/2023
Pharmacy Learning Network
Commentary
Check Twice, Jab Once: How to Make Sure You Are Administering the Correct Vaccine
03/06/2023
Tyler Nichols, PharmD, BCPS
In this commentary, Tyler Nichols, PharmD, discusses common causes of vaccine errors and shares strategies for reducing risk, including storage best practices, technological solutions, and more.
In this commentary, Tyler Nichols, PharmD, discusses common causes of vaccine errors and shares strategies for reducing risk, including storage best practices, technological solutions, and more.
In this commentary, Tyler...
03/06/2023
Pharmacy Learning Network
Stock image of an open pill bottle with medication spilling out in a pharmacy.
Commentary
Drug Diversion and Leadership Response: Tips for Supporting Staff, Patients
02/01/2023
Sadik Owolewa, PharmD
In this commentary, Sadik Owolewa, PharmD, shares 5 strategies for preventing drug diversion with an emphasis on supporting health care workers, promoting a safe environment, and educating patients.
In this commentary, Sadik Owolewa, PharmD, shares 5 strategies for preventing drug diversion with an emphasis on supporting health care workers, promoting a safe environment, and educating patients.
In this commentary, Sadik...
02/01/2023
Pharmacy Learning Network
Stock image of eye and ear drops.
Commentary
An Eye (Drop) for an Eye, and an Ear (Drop) for an Ear
12/22/2022
Tyler Nichols, PharmD, BCPS
Tyler Nichols, PharmD, BCPS, international safe medication management fellow, Institute for Safe Medication Practices, reviews an incident where ear drops were administered in a patient's eye mistakenly and advises what steps may be taken to...
Tyler Nichols, PharmD, BCPS, international safe medication management fellow, Institute for Safe Medication Practices, reviews an incident where ear drops were administered in a patient's eye mistakenly and advises what steps may be taken to...
Tyler Nichols, PharmD, BCPS,...
12/22/2022
Pharmacy Learning Network
Stock image of a pharmacist holding a prescription and bottle of medication
Commentary
Conflict Management: I Don't Remember Learning This in Pharmacy School
12/14/2022
Jose Nery, PharmD
Jose Nery, PharmD, a 2022-2023 safe medication management fellow with ISMP, shares guidance for pharmacists hoping to better navigate conflict with prescribers while addressing concerns over the safety of an order.
Jose Nery, PharmD, a 2022-2023 safe medication management fellow with ISMP, shares guidance for pharmacists hoping to better navigate conflict with prescribers while addressing concerns over the safety of an order.
Jose Nery, PharmD, a 2022-2023...
12/14/2022
Pharmacy Learning Network
Headshot of Reetu Mukherji, MD, Georgetown University
Interview
Evaluating a Digital Tool for Monitoring Drug Toxicities in Patients With Colorectal Cancer
12/12/2022
Maria Asimopoulos
Reetu Mukherji, MD, gastrointestinal medical oncologist, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, discusses findings from her recent study which tested the feasibility of using a smartphone app to monitor...
Reetu Mukherji, MD, gastrointestinal medical oncologist, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, discusses findings from her recent study which tested the feasibility of using a smartphone app to monitor...
Reetu Mukherji, MD,...
12/12/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Still Seeking Answers for Safe Anticoagulation in Patients on Hemodialysis
12/08/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings reviews a study comparing apixaban to warfarin in patients with atrial fibrillation who received hemodialysis for end-stage kidney disease.
Dr Jennings reviews a study comparing apixaban to warfarin in patients with atrial fibrillation who received hemodialysis for end-stage kidney disease.
Dr Jennings reviews a study...
12/08/2022
Pharmacy Learning Network
Headshot of Stephanie Ostling Mason, Glytec, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Improving Glycemic Management for Better Outcomes, Cost Savings
12/07/2022
Maria Asimopoulos
Stephanie Ostling Mason, PharmD, CDCES, diabetes clinical pharmacist, Glytec, shares the challenges associated with insulin management in the hospital setting and offers advice to improve patient outcomes.
Stephanie Ostling Mason, PharmD, CDCES, diabetes clinical pharmacist, Glytec, shares the challenges associated with insulin management in the hospital setting and offers advice to improve patient outcomes.
Stephanie Ostling Mason, PharmD,...
12/07/2022
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
A Series on Medication Safety in the United States: Underutilization of Pharmacists
07/13/2022
Mark A. Munger, PharmD, FCCP, FACC, FHFSA
In the final installment of this series, Dr Munger discusses why pharmacists are uniquely equipped to employ strategies that improve medication safety.  
In the final installment of this series, Dr Munger discusses why pharmacists are uniquely equipped to employ strategies that improve medication safety.  
In the final installment of this...
07/13/2022
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
A Series on Medication Safety in the United States: Effective Strategies to Enhance Safety
07/06/2022
Mark A. Munger, PharmD, FCCP, FACC, FHFSA
In the second installment of this series, Dr Munger shares strategies for providers and health systems to improve medication safety.
In the second installment of this series, Dr Munger shares strategies for providers and health systems to improve medication safety.
In the second installment of...
07/06/2022
Pharmacy Learning Network

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
David T. Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Paul Schulz, MD
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
Ronald Vender, MD, FRCPC
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
Abigail Cline, MD, PhD
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; Ryan Nix, BS, NRP, NCI
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
Videos
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
05/13/2020
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of...
05/13/2020
Pharmacy Learning Network
Videos
Diabetes - Guideline Changes, Adherence, and Newer Drug Issues
09/15/2015
09/15/2015
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use